Calcium Channel Blockers and Risk of Lymphedema among Breast Cancer Patients: Nested Case-Control Study.

Stolarz, Amanda J; Lakkad, Mrinmayee; Klimberg, V Suzanne; Painter, Jacob T

Stolarz, Amanda J; Lakkad, Mrinmayee; Klimberg, V Suzanne; Painter, Jacob T.

Afiliação

Stolarz AJ; Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Lakkad M; Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Klimberg VS; Division of Surgical Oncology, Department of Surgery, University of Texas Medical Branch, Galveston, Texas.
Painter JT; Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, Arkansas. jtpainter@uams.edu.

Cancer Epidemiol Biomarkers Prev ; 28(11): 1809-1815, 2019 Nov.

Article em En | MEDLINE | ID: mdl-31399477

Assuntos

Neoplasias da Mama/complicações; Bloqueadores dos Canais de Cálcio/efeitos adversos; Linfedema/induzido quimicamente; Bloqueadores dos Canais de Cálcio/farmacologia; Estudos de Casos e Controles; Feminino; Humanos; Estudos Retrospectivos; Fatores de Risco

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Bloqueadores dos Canais de Cálcio / Linfedema Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google